263 related articles for article (PubMed ID: 18243838)
21. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
22. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
23. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
[TBL] [Abstract][Full Text] [Related]
25. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
[TBL] [Abstract][Full Text] [Related]
26. RNA interference-mediated prevention and therapy for hepatocellular carcinoma.
Romano PR; McCallus DE; Pachuk CJ
Oncogene; 2006 Jun; 25(27):3857-65. PubMed ID: 16799627
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
28. Current treatment for hepatocellular carcinoma.
Cahill BA; Braccia D
Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
[TBL] [Abstract][Full Text] [Related]
29. Treatment options for hepatocellular carcinoma.
Sandhu DS; Tharayil VS; Lai JP; Roberts LR
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
[TBL] [Abstract][Full Text] [Related]
30. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
[TBL] [Abstract][Full Text] [Related]
33. Opportunities for targeted therapies in hepatocellular carcinoma.
Thomas MB; Abbruzzese JL
J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
[TBL] [Abstract][Full Text] [Related]
34. [Nonsurgical treatment of hepatocellular carcinoma].
Raoul JL; Boucher E; Kerbrat P
Bull Cancer; 1999 Jun; 86(6):537-43. PubMed ID: 10417427
[TBL] [Abstract][Full Text] [Related]
35. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
36. New aspects of diagnosis and therapy of hepatocellular carcinoma.
Bruix J; Hessheimer AJ; Forner A; Boix L; Vilana R; Llovet JM
Oncogene; 2006 Jun; 25(27):3848-56. PubMed ID: 16799626
[TBL] [Abstract][Full Text] [Related]
37. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of hepatocellular carcinoma.
Bosch FX; Ribes J; Cléries R; Díaz M
Clin Liver Dis; 2005 May; 9(2):191-211, v. PubMed ID: 15831268
[TBL] [Abstract][Full Text] [Related]
39. [A case of arterial chemoembolization for hepatocellular carcinoma with 11 years of survival].
Iozzino M; Spaziani E; Saltarelli A; Notarianni E; Di Filippo A; Picchio M; Ceci F; De Angelis F; Cipriani B; Nardecchia G; Nicodemi S; Stagnitti F; Cianni R
G Chir; 2008 Oct; 29(10):432-6. PubMed ID: 18947469
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
Kim SR; Kudo M; Hino O; Han KH; Chung YH; Lee HS;
Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
